Practical Implications for Treatment Strategies in Advanced Ovarian Cancer

home / peer-exchange / practical-implications-for-treatment-strategies-in-advanced-ovarian-cancer

EP. 1: An Introduction to the Discussion of Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 2: Biomarker-Driven Frontline Ovarian Cancer Treatment

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 3: The Impact of PAOLA-1 on Frontline Treatment of Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 4: Impact of HRD Status on Frontline Treatment of Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 5: Need for Frontline Comparison Trials in Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 6: Treating BRCA+ Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 7: Treating Homologous Recombination Proficient Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 8: Personalized Dosing of Niraparib in Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 9: NCCN Guidelines and FDA Approvals for Treating Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 10: PAOLA-1 Study Surgical Subset for Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 11: Patient Preference for Treatment in Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 12: Emerging Combinations in the Frontline Setting of Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 13: Expert Approaches for Treating Recurrent Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 14: PARP Inhibitors in Recurrent Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 15: New Data for Secondary Surgery in Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 16: Neoadjuvant Therapy Versus Surgery for Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 17: Antibody Drug Conjugates for Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 18: Emerging Therapies in Recurrent Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

EP. 19: Upcoming Clinical Trials for Ovarian Cancer

By Bradley J. Monk, MD, FACOG, FACS, Creighton University School of Medicine at St. Joseph's Hospital and Arizona Oncology
Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

July 20th 2020

Latest Conference Coverage

As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority

Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD

Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma

Serial ctDNA Testing Could Improve Risk Stratification in High-Risk MIBC

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512